This trial is not accepting new applicants

The study Study of Lutetium (177Lu) Vipivotide Tetraxetan in mCRPC Participants With Moderately and Severely Impaired and With Normal Renal Function is currently active not recruiting. You can still browse other paid trials that may be a fit.